Buprenorphine Patch, Extended Release
Product Images NDC 50742-376
Product Visual Gallery
This gallery contains 29 technical images submitted to the FDA as part of the official labeling for Buprenorphine (NDC 50742-376). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ingenus Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Structure (Structure Slc 0054)
Fig1 (Fig1 Slc 0054)
Fig2 (Fig2 Slc 0054)
Fig3 (Fig3 Slc 0054)
Fig4 (Fig4 Slc 0054)
Logo (Logo)
Logo (Logo01)
Image Description (Figa Slc 0054)
Image Description (Figb Slc 0054)
Image Description (Figc Slc 0054)
Image Description (Figd Slc 0054)
Image Description (Fige Slc 0054)
Image Description (Figf Slc 0054)
Image Description (Figg Slc 0054)
Image Description (Figh Slc 0054)
Image Description (Figi Slc 0054)
Image Description (Figj Slc 0054)
Image Description (Figk Slc 0054)
Image Description (Figl Slc 0054)
Image Description (Figm Slc 0054)
Image Description (Fign Slc 0054)
Image Description (Figo Slc 0054)
Image Description (Logo02)
Carton-10mcg (Carton 5mcg)
Carton-7.5mcg (Carton 7.5mcg)
Carton-10mcg (Carton 10mcg)
Carton-15mcg (Carton 15mcg)
Carton-20mcg (Carton 20mcg)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.